nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP1A2—type 2 diabetes mellitus	0.191	0.602	CbGaD
Nevirapine—CYP3A4—type 2 diabetes mellitus	0.126	0.398	CbGaD
Nevirapine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0461	0.0973	CbGbCtD
Nevirapine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0238	0.0502	CbGbCtD
Nevirapine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0217	0.0459	CbGbCtD
Nevirapine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0202	0.0426	CbGbCtD
Nevirapine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0194	0.041	CbGbCtD
Nevirapine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0176	0.0371	CbGbCtD
Nevirapine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0172	0.0363	CbGbCtD
Nevirapine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0172	0.0363	CbGbCtD
Nevirapine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0159	0.0335	CbGbCtD
Nevirapine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0157	0.0332	CbGbCtD
Nevirapine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0155	0.0327	CbGbCtD
Nevirapine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0153	0.0323	CbGbCtD
Nevirapine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0145	0.0306	CbGbCtD
Nevirapine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.014	0.0296	CbGbCtD
Nevirapine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0139	0.0292	CbGbCtD
Nevirapine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0138	0.0292	CbGbCtD
Nevirapine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0131	0.0277	CbGbCtD
Nevirapine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.013	0.0275	CbGbCtD
Nevirapine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0126	0.0267	CbGbCtD
Nevirapine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0125	0.0263	CbGbCtD
Nevirapine—CYP3A5—Losartan—type 2 diabetes mellitus	0.012	0.0253	CbGbCtD
Nevirapine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0119	0.0251	CbGbCtD
Nevirapine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0114	0.0241	CbGbCtD
Nevirapine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0111	0.0233	CbGbCtD
Nevirapine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.01	0.0211	CbGbCtD
Nevirapine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00893	0.0188	CbGbCtD
Nevirapine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0088	0.0186	CbGbCtD
Nevirapine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00805	0.017	CbGbCtD
Nevirapine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00758	0.016	CbGbCtD
Nevirapine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00726	0.0153	CbGbCtD
Nevirapine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00726	0.0153	CbGbCtD
Nevirapine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00687	0.0145	CbGbCtD
Nevirapine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00512	0.0108	CbGbCtD
Nevirapine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00468	0.00987	CbGbCtD
Nevirapine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000129	0.000825	CcSEcCtD
Nevirapine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000129	0.000825	CcSEcCtD
Nevirapine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000129	0.000823	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000129	0.00082	CcSEcCtD
Nevirapine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000128	0.000819	CcSEcCtD
Nevirapine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000128	0.000817	CcSEcCtD
Nevirapine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000128	0.000816	CcSEcCtD
Nevirapine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000128	0.000814	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000127	0.00081	CcSEcCtD
Nevirapine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000126	0.000806	CcSEcCtD
Nevirapine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000126	0.000803	CcSEcCtD
Nevirapine—Malaise—Metformin—type 2 diabetes mellitus	0.000125	0.000796	CcSEcCtD
Nevirapine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000125	0.000796	CcSEcCtD
Nevirapine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000124	0.000793	CcSEcCtD
Nevirapine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000124	0.000792	CcSEcCtD
Nevirapine—Oedema—Valsartan—type 2 diabetes mellitus	0.000124	0.000791	CcSEcCtD
Nevirapine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000124	0.000791	CcSEcCtD
Nevirapine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000124	0.00079	CcSEcCtD
Nevirapine—Rash—Glipizide—type 2 diabetes mellitus	0.000123	0.000786	CcSEcCtD
Nevirapine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000123	0.000785	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000123	0.000785	CcSEcCtD
Nevirapine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000123	0.000784	CcSEcCtD
Nevirapine—Erythema—Losartan—type 2 diabetes mellitus	0.000123	0.000784	CcSEcCtD
Nevirapine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000123	0.000782	CcSEcCtD
Nevirapine—Oedema—Orlistat—type 2 diabetes mellitus	0.000123	0.000782	CcSEcCtD
Nevirapine—Headache—Glipizide—type 2 diabetes mellitus	0.000122	0.000781	CcSEcCtD
Nevirapine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000122	0.000776	CcSEcCtD
Nevirapine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000121	0.000775	CcSEcCtD
Nevirapine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000121	0.000773	CcSEcCtD
Nevirapine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000121	0.000773	CcSEcCtD
Nevirapine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000121	0.000772	CcSEcCtD
Nevirapine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000121	0.00077	CcSEcCtD
Nevirapine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00012	0.000769	CcSEcCtD
Nevirapine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00012	0.000767	CcSEcCtD
Nevirapine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00012	0.000766	CcSEcCtD
Nevirapine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000119	0.000762	CcSEcCtD
Nevirapine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000119	0.000761	CcSEcCtD
Nevirapine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000119	0.000759	CcSEcCtD
Nevirapine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000119	0.000759	CcSEcCtD
Nevirapine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000119	0.000758	CcSEcCtD
Nevirapine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000118	0.000754	CcSEcCtD
Nevirapine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000753	CcSEcCtD
Nevirapine—Myalgia—Metformin—type 2 diabetes mellitus	0.000118	0.000752	CcSEcCtD
Nevirapine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000118	0.000751	CcSEcCtD
Nevirapine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000117	0.000748	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000117	0.000746	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000117	0.000744	CcSEcCtD
Nevirapine—Discomfort—Metformin—type 2 diabetes mellitus	0.000116	0.000743	CcSEcCtD
Nevirapine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000116	0.000742	CcSEcCtD
Nevirapine—Nausea—Glipizide—type 2 diabetes mellitus	0.000116	0.00074	CcSEcCtD
Nevirapine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000116	0.000739	CcSEcCtD
Nevirapine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000737	CcSEcCtD
Nevirapine—Pain—Gliclazide—type 2 diabetes mellitus	0.000115	0.000736	CcSEcCtD
Nevirapine—Rash—Glimepiride—type 2 diabetes mellitus	0.000115	0.000733	CcSEcCtD
Nevirapine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000115	0.000733	CcSEcCtD
Nevirapine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000731	CcSEcCtD
Nevirapine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00073	CcSEcCtD
Nevirapine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000114	0.00073	CcSEcCtD
Nevirapine—Headache—Glimepiride—type 2 diabetes mellitus	0.000114	0.000729	CcSEcCtD
Nevirapine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000114	0.000727	CcSEcCtD
Nevirapine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000726	CcSEcCtD
Nevirapine—Anaemia—Losartan—type 2 diabetes mellitus	0.000114	0.000725	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000113	0.000721	CcSEcCtD
Nevirapine—Oedema—Metformin—type 2 diabetes mellitus	0.000113	0.000721	CcSEcCtD
Nevirapine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.000718	CcSEcCtD
Nevirapine—Angioedema—Losartan—type 2 diabetes mellitus	0.000112	0.000716	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000112	0.000712	CcSEcCtD
Nevirapine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000111	0.00071	CcSEcCtD
Nevirapine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000111	0.00071	CcSEcCtD
Nevirapine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000709	CcSEcCtD
Nevirapine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000709	CcSEcCtD
Nevirapine—Malaise—Losartan—type 2 diabetes mellitus	0.000111	0.000707	CcSEcCtD
Nevirapine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000111	0.000707	CcSEcCtD
Nevirapine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000111	0.000707	CcSEcCtD
Nevirapine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000111	0.000705	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00011	0.000704	CcSEcCtD
Nevirapine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00011	0.000704	CcSEcCtD
Nevirapine—Somnolence—Valsartan—type 2 diabetes mellitus	0.00011	0.000703	CcSEcCtD
Nevirapine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00011	0.000702	CcSEcCtD
Nevirapine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00011	0.000701	CcSEcCtD
Nevirapine—Skin disorder—Metformin—type 2 diabetes mellitus	0.00011	0.0007	CcSEcCtD
Nevirapine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000698	CcSEcCtD
Nevirapine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000108	0.000691	CcSEcCtD
Nevirapine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000108	0.000689	CcSEcCtD
Nevirapine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000108	0.000688	CcSEcCtD
Nevirapine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000108	0.000688	CcSEcCtD
Nevirapine—Anorexia—Metformin—type 2 diabetes mellitus	0.000108	0.000687	CcSEcCtD
Nevirapine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000107	0.000684	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000107	0.000683	CcSEcCtD
Nevirapine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000107	0.000682	CcSEcCtD
Nevirapine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000107	0.000681	CcSEcCtD
Nevirapine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000107	0.000681	CcSEcCtD
Nevirapine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000107	0.00068	CcSEcCtD
Nevirapine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000107	0.00068	CcSEcCtD
Nevirapine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000107	0.00068	CcSEcCtD
Nevirapine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000106	0.000679	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000106	0.000675	CcSEcCtD
Nevirapine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000106	0.000674	CcSEcCtD
Nevirapine—Erythema—Ramipril—type 2 diabetes mellitus	0.000105	0.000672	CcSEcCtD
Nevirapine—Pain—Orlistat—type 2 diabetes mellitus	0.000105	0.000669	CcSEcCtD
Nevirapine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000105	0.000668	CcSEcCtD
Nevirapine—Myalgia—Losartan—type 2 diabetes mellitus	0.000105	0.000668	CcSEcCtD
Nevirapine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000667	CcSEcCtD
Nevirapine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000105	0.000667	CcSEcCtD
Nevirapine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000666	CcSEcCtD
Nevirapine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000661	CcSEcCtD
Nevirapine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000661	CcSEcCtD
Nevirapine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.00066	CcSEcCtD
Nevirapine—Discomfort—Losartan—type 2 diabetes mellitus	0.000103	0.00066	CcSEcCtD
Nevirapine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000657	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000103	0.000656	CcSEcCtD
Nevirapine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000103	0.000656	CcSEcCtD
Nevirapine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000648	CcSEcCtD
Nevirapine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000101	0.000647	CcSEcCtD
Nevirapine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000101	0.000647	CcSEcCtD
Nevirapine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000101	0.000644	CcSEcCtD
Nevirapine—Somnolence—Metformin—type 2 diabetes mellitus	0.0001	0.000641	CcSEcCtD
Nevirapine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.0001	0.00064	CcSEcCtD
Nevirapine—Oedema—Losartan—type 2 diabetes mellitus	0.0001	0.00064	CcSEcCtD
Nevirapine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.0001	0.000639	CcSEcCtD
Nevirapine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.95e-05	0.000634	CcSEcCtD
Nevirapine—Urticaria—Valsartan—type 2 diabetes mellitus	9.85e-05	0.000629	CcSEcCtD
Nevirapine—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.84e-05	0.000628	CcSEcCtD
Nevirapine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.82e-05	0.000627	CcSEcCtD
Nevirapine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.82e-05	0.000626	CcSEcCtD
Nevirapine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000625	CcSEcCtD
Nevirapine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.78e-05	0.000624	CcSEcCtD
Nevirapine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.77e-05	0.000623	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.75e-05	0.000622	CcSEcCtD
Nevirapine—Fatigue—Metformin—type 2 diabetes mellitus	9.74e-05	0.000621	CcSEcCtD
Nevirapine—Urticaria—Orlistat—type 2 diabetes mellitus	9.74e-05	0.000621	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.00062	CcSEcCtD
Nevirapine—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000618	CcSEcCtD
Nevirapine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000618	CcSEcCtD
Nevirapine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.69e-05	0.000618	CcSEcCtD
Nevirapine—Angioedema—Ramipril—type 2 diabetes mellitus	9.63e-05	0.000614	CcSEcCtD
Nevirapine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.57e-05	0.000611	CcSEcCtD
Nevirapine—Anorexia—Losartan—type 2 diabetes mellitus	9.56e-05	0.00061	CcSEcCtD
Nevirapine—Vomiting—Glyburide—type 2 diabetes mellitus	9.56e-05	0.00061	CcSEcCtD
Nevirapine—Pruritus—Gliclazide—type 2 diabetes mellitus	9.55e-05	0.000609	CcSEcCtD
Nevirapine—Malaise—Ramipril—type 2 diabetes mellitus	9.5e-05	0.000606	CcSEcCtD
Nevirapine—Rash—Glyburide—type 2 diabetes mellitus	9.48e-05	0.000605	CcSEcCtD
Nevirapine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.48e-05	0.000604	CcSEcCtD
Nevirapine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.47e-05	0.000604	CcSEcCtD
Nevirapine—Headache—Glyburide—type 2 diabetes mellitus	9.42e-05	0.000601	CcSEcCtD
Nevirapine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.31e-05	0.000594	CcSEcCtD
Nevirapine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000591	CcSEcCtD
Nevirapine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.24e-05	0.000589	CcSEcCtD
Nevirapine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.24e-05	0.000589	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.2e-05	0.000587	CcSEcCtD
Nevirapine—Fatigue—Irbesartan—type 2 diabetes mellitus	9.19e-05	0.000586	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.14e-05	0.000583	CcSEcCtD
Nevirapine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.14e-05	0.000583	CcSEcCtD
Nevirapine—Pain—Irbesartan—type 2 diabetes mellitus	9.12e-05	0.000581	CcSEcCtD
Nevirapine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.03e-05	0.000576	CcSEcCtD
Nevirapine—Paraesthesia—Losartan—type 2 diabetes mellitus	9.01e-05	0.000575	CcSEcCtD
Nevirapine—Urticaria—Metformin—type 2 diabetes mellitus	8.97e-05	0.000572	CcSEcCtD
Nevirapine—Myalgia—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000572	CcSEcCtD
Nevirapine—Arthralgia—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000572	CcSEcCtD
Nevirapine—Nausea—Glyburide—type 2 diabetes mellitus	8.93e-05	0.00057	CcSEcCtD
Nevirapine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.93e-05	0.00057	CcSEcCtD
Nevirapine—Somnolence—Losartan—type 2 diabetes mellitus	8.92e-05	0.000569	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.91e-05	0.000568	CcSEcCtD
Nevirapine—Asthenia—Valsartan—type 2 diabetes mellitus	8.9e-05	0.000568	CcSEcCtD
Nevirapine—Discomfort—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000566	CcSEcCtD
Nevirapine—Asthenia—Orlistat—type 2 diabetes mellitus	8.79e-05	0.000561	CcSEcCtD
Nevirapine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.78e-05	0.00056	CcSEcCtD
Nevirapine—Pruritus—Valsartan—type 2 diabetes mellitus	8.78e-05	0.00056	CcSEcCtD
Nevirapine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.72e-05	0.000556	CcSEcCtD
Nevirapine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.72e-05	0.000556	CcSEcCtD
Nevirapine—Pruritus—Orlistat—type 2 diabetes mellitus	8.67e-05	0.000553	CcSEcCtD
Nevirapine—Fatigue—Losartan—type 2 diabetes mellitus	8.65e-05	0.000552	CcSEcCtD
Nevirapine—Oedema—Ramipril—type 2 diabetes mellitus	8.6e-05	0.000549	CcSEcCtD
Nevirapine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.6e-05	0.000549	CcSEcCtD
Nevirapine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.58e-05	0.000548	CcSEcCtD
Nevirapine—Pain—Losartan—type 2 diabetes mellitus	8.58e-05	0.000547	CcSEcCtD
Nevirapine—Rash—Gliclazide—type 2 diabetes mellitus	8.51e-05	0.000543	CcSEcCtD
Nevirapine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.5e-05	0.000542	CcSEcCtD
Nevirapine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.49e-05	0.000541	CcSEcCtD
Nevirapine—Urticaria—Irbesartan—type 2 diabetes mellitus	8.47e-05	0.00054	CcSEcCtD
Nevirapine—Headache—Gliclazide—type 2 diabetes mellitus	8.46e-05	0.00054	CcSEcCtD
Nevirapine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000538	CcSEcCtD
Nevirapine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000538	CcSEcCtD
Nevirapine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000538	CcSEcCtD
Nevirapine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000537	CcSEcCtD
Nevirapine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.39e-05	0.000535	CcSEcCtD
Nevirapine—Skin disorder—Ramipril—type 2 diabetes mellitus	8.36e-05	0.000533	CcSEcCtD
Nevirapine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.27e-05	0.000527	CcSEcCtD
Nevirapine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.2e-05	0.000523	CcSEcCtD
Nevirapine—Anorexia—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000523	CcSEcCtD
Nevirapine—Asthenia—Metformin—type 2 diabetes mellitus	8.1e-05	0.000517	CcSEcCtD
Nevirapine—Nausea—Gliclazide—type 2 diabetes mellitus	8.02e-05	0.000512	CcSEcCtD
Nevirapine—Pruritus—Metformin—type 2 diabetes mellitus	7.99e-05	0.00051	CcSEcCtD
Nevirapine—Urticaria—Losartan—type 2 diabetes mellitus	7.97e-05	0.000508	CcSEcCtD
Nevirapine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.93e-05	0.000506	CcSEcCtD
Nevirapine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.93e-05	0.000506	CcSEcCtD
Nevirapine—Vomiting—Valsartan—type 2 diabetes mellitus	7.89e-05	0.000503	CcSEcCtD
Nevirapine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.85e-05	0.000501	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.84e-05	0.0005	CcSEcCtD
Nevirapine—Rash—Valsartan—type 2 diabetes mellitus	7.82e-05	0.000499	CcSEcCtD
Nevirapine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.81e-05	0.000498	CcSEcCtD
Nevirapine—Vomiting—Orlistat—type 2 diabetes mellitus	7.79e-05	0.000497	CcSEcCtD
Nevirapine—Headache—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000496	CcSEcCtD
Nevirapine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.73e-05	0.000493	CcSEcCtD
Nevirapine—Rash—Orlistat—type 2 diabetes mellitus	7.73e-05	0.000493	CcSEcCtD
Nevirapine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000493	CcSEcCtD
Nevirapine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.72e-05	0.000493	CcSEcCtD
Nevirapine—Headache—Orlistat—type 2 diabetes mellitus	7.68e-05	0.00049	CcSEcCtD
Nevirapine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000488	CcSEcCtD
Nevirapine—Somnolence—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000488	CcSEcCtD
Nevirapine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000481	CcSEcCtD
Nevirapine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000477	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.43e-05	0.000474	CcSEcCtD
Nevirapine—Fatigue—Ramipril—type 2 diabetes mellitus	7.42e-05	0.000473	CcSEcCtD
Nevirapine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.39e-05	0.000471	CcSEcCtD
Nevirapine—Nausea—Valsartan—type 2 diabetes mellitus	7.37e-05	0.00047	CcSEcCtD
Nevirapine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.29e-05	0.000465	CcSEcCtD
Nevirapine—Nausea—Orlistat—type 2 diabetes mellitus	7.28e-05	0.000464	CcSEcCtD
Nevirapine—Asthenia—Losartan—type 2 diabetes mellitus	7.2e-05	0.000459	CcSEcCtD
Nevirapine—Vomiting—Metformin—type 2 diabetes mellitus	7.18e-05	0.000458	CcSEcCtD
Nevirapine—Rash—Metformin—type 2 diabetes mellitus	7.12e-05	0.000454	CcSEcCtD
Nevirapine—Dermatitis—Metformin—type 2 diabetes mellitus	7.12e-05	0.000454	CcSEcCtD
Nevirapine—Pruritus—Losartan—type 2 diabetes mellitus	7.1e-05	0.000453	CcSEcCtD
Nevirapine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000452	CcSEcCtD
Nevirapine—Headache—Metformin—type 2 diabetes mellitus	7.08e-05	0.000451	CcSEcCtD
Nevirapine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000449	CcSEcCtD
Nevirapine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.86e-05	0.000438	CcSEcCtD
Nevirapine—Urticaria—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000436	CcSEcCtD
Nevirapine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000434	CcSEcCtD
Nevirapine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000434	CcSEcCtD
Nevirapine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000432	CcSEcCtD
Nevirapine—Rash—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.000429	CcSEcCtD
Nevirapine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000428	CcSEcCtD
Nevirapine—Nausea—Metformin—type 2 diabetes mellitus	6.71e-05	0.000428	CcSEcCtD
Nevirapine—Headache—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000426	CcSEcCtD
Nevirapine—Vomiting—Losartan—type 2 diabetes mellitus	6.38e-05	0.000407	CcSEcCtD
Nevirapine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.34e-05	0.000404	CcSEcCtD
Nevirapine—Nausea—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.000404	CcSEcCtD
Nevirapine—Rash—Losartan—type 2 diabetes mellitus	6.33e-05	0.000403	CcSEcCtD
Nevirapine—Dermatitis—Losartan—type 2 diabetes mellitus	6.32e-05	0.000403	CcSEcCtD
Nevirapine—Headache—Losartan—type 2 diabetes mellitus	6.28e-05	0.000401	CcSEcCtD
Nevirapine—Asthenia—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000394	CcSEcCtD
Nevirapine—Pruritus—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000388	CcSEcCtD
Nevirapine—Nausea—Losartan—type 2 diabetes mellitus	5.96e-05	0.00038	CcSEcCtD
Nevirapine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000375	CcSEcCtD
Nevirapine—Vomiting—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000349	CcSEcCtD
Nevirapine—Rash—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000346	CcSEcCtD
Nevirapine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000346	CcSEcCtD
Nevirapine—Headache—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000344	CcSEcCtD
Nevirapine—Nausea—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000326	CcSEcCtD
Nevirapine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.54e-06	0.000127	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.53e-06	0.000126	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	6.5e-06	0.000126	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.48e-06	0.000125	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.46e-06	0.000125	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.42e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.42e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.42e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.42e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.4e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	6.4e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.4e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.38e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	6.38e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	6.37e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.35e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.31e-06	0.000122	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	6.28e-06	0.000122	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.25e-06	0.000121	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	6.25e-06	0.000121	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	6.23e-06	0.000121	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	6.18e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	6.14e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	6.1e-06	0.000118	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	6.07e-06	0.000118	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	6.05e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.04e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	5.98e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5.96e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.95e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.95e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.95e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	5.94e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.92e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.9e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.9e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.9e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.89e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.84e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	5.83e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.8e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.79e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.79e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.77e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.77e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.74e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	5.7e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.69e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	5.68e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.67e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.66e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.66e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.65e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.62e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.62e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.62e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.62e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.62e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.59e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.57e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.56e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	5.54e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.49e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.47e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.46e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.46e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.46e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.46e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.44e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.42e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.41e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.4e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.38e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.38e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.34e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.34e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.34e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	5.27e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.25e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	5.25e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.24e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.2e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.18e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	5.17e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.16e-06	9.99e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.16e-06	9.99e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	5.15e-06	9.96e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	5.13e-06	9.93e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.12e-06	9.9e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.12e-06	9.9e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.06e-06	9.79e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.04e-06	9.76e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.04e-06	9.76e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.04e-06	9.76e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	5.03e-06	9.74e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.98e-06	9.65e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.95e-06	9.58e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.9e-06	9.49e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.9e-06	9.49e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.88e-06	9.45e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.87e-06	9.43e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.87e-06	9.42e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.84e-06	9.36e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.83e-06	9.35e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.8e-06	9.29e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.79e-06	9.27e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.77e-06	9.24e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	4.74e-06	9.18e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.72e-06	9.13e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.61e-06	8.93e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.56e-06	8.83e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.54e-06	8.8e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.53e-06	8.78e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	4.53e-06	8.78e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.45e-06	8.62e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.45e-06	8.62e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.45e-06	8.61e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.45e-06	8.61e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.45e-06	8.61e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.43e-06	8.57e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.42e-06	8.56e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.41e-06	8.54e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.41e-06	8.54e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.39e-06	8.5e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.37e-06	8.46e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.37e-06	8.46e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.37e-06	8.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.37e-06	8.45e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.34e-06	8.4e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.34e-06	8.4e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.34e-06	8.4e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.33e-06	8.38e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.31e-06	8.35e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	4.25e-06	8.23e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.24e-06	8.21e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.23e-06	8.2e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.2e-06	8.14e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.19e-06	8.1e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	4.17e-06	8.08e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	4.16e-06	8.05e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	4.15e-06	8.03e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.13e-06	7.99e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.09e-06	7.92e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	4.08e-06	7.89e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.05e-06	7.84e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.01e-06	7.77e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.96e-06	7.67e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.95e-06	7.65e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.93e-06	7.61e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.92e-06	7.58e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.89e-06	7.53e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.89e-06	7.53e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.89e-06	7.53e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.85e-06	7.45e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.82e-06	7.4e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.82e-06	7.39e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.81e-06	7.38e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.8e-06	7.35e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.79e-06	7.33e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.77e-06	7.29e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.77e-06	7.29e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.77e-06	7.29e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.75e-06	7.26e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.74e-06	7.24e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.7e-06	7.17e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.7e-06	7.16e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.66e-06	7.08e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.66e-06	7.08e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.65e-06	7.06e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.61e-06	7e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.59e-06	6.95e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.58e-06	6.92e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.58e-06	6.92e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.58e-06	6.92e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.56e-06	6.89e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.55e-06	6.86e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.52e-06	6.81e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.52e-06	6.81e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.49e-06	6.77e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.46e-06	6.71e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.43e-06	6.65e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.43e-06	6.64e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.41e-06	6.59e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.39e-06	6.57e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.38e-06	6.54e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.37e-06	6.53e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.37e-06	6.53e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.36e-06	6.51e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.36e-06	6.5e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.36e-06	6.5e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.35e-06	6.48e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	3.35e-06	6.48e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.33e-06	6.44e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.27e-06	6.33e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.26e-06	6.31e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.22e-06	6.23e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.09e-06	5.98e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.03e-06	5.87e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.96e-06	5.72e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.93e-06	5.68e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.93e-06	5.67e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.91e-06	5.63e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.91e-06	5.63e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.9e-06	5.61e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.89e-06	5.6e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.89e-06	5.59e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.88e-06	5.57e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.87e-06	5.56e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.86e-06	5.53e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.84e-06	5.5e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.77e-06	5.37e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.7e-06	5.22e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.66e-06	5.15e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.65e-06	5.12e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.64e-06	5.1e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.59e-06	5.02e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.58e-06	5e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.54e-06	4.92e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.54e-06	4.92e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.52e-06	4.88e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.52e-06	4.88e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.52e-06	4.87e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.5e-06	4.85e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.48e-06	4.81e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.46e-06	4.76e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.38e-06	4.61e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.34e-06	4.53e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.33e-06	4.5e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.31e-06	4.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.26e-06	4.38e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.25e-06	4.36e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.23e-06	4.31e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.22e-06	4.3e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.19e-06	4.25e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.15e-06	4.17e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.15e-06	4.17e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	2.08e-06	4.04e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.97e-06	3.81e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.93e-06	3.74e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.9e-06	3.67e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.74e-06	3.36e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.68e-06	3.26e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.66e-06	3.22e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.66e-06	3.22e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.64e-06	3.18e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.52e-06	2.94e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-06	2.26e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	2.24e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	9.9e-07	1.92e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.64e-07	1.48e-05	CbGpPWpGaD
